Clearbridge Health

The new shares will be issued at 50% discount off Biolidic's last traded price

Clearbridge Health's Covid-19 ART test receives approval by Philippines

The group’s first shipment of the Sinopharm vaccine had arrived on Aug 28 and was fully allocated by early Sept.

The vaccine has been listed by the WHO for emergency use.

Take a look at these six stocks this week, including Haidilao, Clearbridge Health and Penguin International.

PhillipCapital has maintained its “buy” rating and target price of 26 cents on ClearBridge Health on the back of a stronger 2H20 for the company.

This JV partner claims that a certain notarial deed has been made unlawfully, and is seeking damages of $102 million.

Healthcare companies are now in the spotlight as the Covid-19 pandemic continues. Listed companies such as Biolidics and Q&M Dental Group have announced their intention to produce Covid-19 test kits. And markets have reacted accordingly.

Singapore firm Biolidics launches a rapid test kit that will identify confirmed cases of Covid-19 within 10 minutes.

“We see high growth potential for the company as doctors increasingly customise treatments to patients’ genetic composition,” says analyst Liu Jinshu.